Safer Supply: Program Discontinuation and re-engagement

Since 2016, nearly 50,000 people who use drugs have died as a result of the toxic unregulated drug supply. Safer supply programs provide people who use drugs with daily access to pharmaceutical-grade prescription medication as an alternative to the toxic unregulated drug supply. We conducted a qualitative study with safer supply participants to better understand program discontinuation, re-engagement, and barriers to care from their perspective. Semi-structured interviews and surveys were completed with participants. Overall, 30 individuals participated in this study. Three major themes were brought up by research participants, which include: (1) safer supply program entry, (2) safer supply program experiences, and (3) the program restart process. Discussions with participants highlighted the importance of recognizing that times of crisis are inevitable and may potentially threaten participant program retention. Having clear program processes in place, increased wrap-around services, and flexibility when provisioning care are essential components of safer supply programs.